Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Tools & Technology » PCR » NIH RADx Program Awards $29.3M to Increase SARS-CoV-2 Testing Capacity

NIH RADx Program Awards $29.3M to Increase SARS-CoV-2 Testing Capacity

Apr 06, 2021
|
staff reporter

NEW YORK – The US National Institutes of Health announced on Monday that it has awarded $29.3 million in new contracts to diagnostic firms to increase SARS-CoV-2 testing capacity at the point of care and in laboratories.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

Breathe It Out

Researchers are developing a breath test to determine how severe patients' methylmalonic acidemia disease is, FierceBiotech reports.

The Next Batch

NPR reports that vaccine developers are working on SARS-CoV-2 vaccines that are easier to store or administer than the current crop.

Switch for the Second

Reuters reports that France is to recommend that people under 55 who received one dose of AstraZeneca's SARS-CoV-2 vaccine receive a different vaccine for their second dose.

Science Reviews How Non-Genetic DNA Features Expand Utility of Liquid Biopsies, Presents Study of Enzymes in DNA Methylation

In Science this week: review discusses advances in liquid biopsies, and more.

What's Popular?

In COVID-19

  1. Novacyt in Dispute with UK Department of Health and Social Care Over Coronavirus Test Contract

  2. Hologic to Acquire Finnish MDx Firm Mobidiag for Approximately $795M

  3. Cleveland Clinic, IBM Look to Future With Quantum Computing Collaboration

    Premium

  4. Using CRISPR-Chip Technology, Cardea Bio Aims to Develop Lab-Free Multi-Omic Technology

    Premium

  5. Illumina Preliminary Q1 Revenues Grow 26 Percent

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2021 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.